These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 23881249

  • 1. Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies.
    Steinberg BA, Hasselblad V, Atwater BD, Bahnson TD, Washam JB, Alexander JH, Daubert JP, Piccini JP.
    J Interv Card Electrophysiol; 2013 Sep; 37(3):213-21. PubMed ID: 23881249
    [Abstract] [Full Text] [Related]

  • 2. Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation.
    Haines DE, Mead-Salley M, Salazar M, Marchlinski FE, Zado E, Calkins H, Yarmohammadi H, Nademanee K, Amnueypol M, Skanes AC, Saklani P.
    J Interv Card Electrophysiol; 2013 Sep; 37(3):233-9. PubMed ID: 23740224
    [Abstract] [Full Text] [Related]

  • 3. Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay.
    Imamura K, Yoshida A, Takei A, Fukuzawa K, Kiuchi K, Takami K, Takami M, Itoh M, Fujiwara R, Suzuki A, Nakanishi T, Yamashita S, Matsumoto A, Hirata K.
    J Interv Card Electrophysiol; 2013 Sep; 37(3):223-31. PubMed ID: 23585240
    [Abstract] [Full Text] [Related]

  • 4. Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.
    Kaiser DW, Streur MM, Nagarakanti R, Whalen SP, Ellis CR.
    J Interv Card Electrophysiol; 2013 Sep; 37(3):241-7. PubMed ID: 23625091
    [Abstract] [Full Text] [Related]

  • 5. Periprocedural dabigatran anticoagulation for atrial fibrillation ablation: do we have enough information to make a rational decision.
    Noheria A, Asirvatham SJ.
    J Interv Card Electrophysiol; 2013 Sep; 37(3):209-11. PubMed ID: 23892446
    [No Abstract] [Full Text] [Related]

  • 6. Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban.
    Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA.
    Europace; 2014 Oct; 16(10):1443-9. PubMed ID: 25115168
    [Abstract] [Full Text] [Related]

  • 7. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D, Reddy YM, Di Biase L, Vanga SR, Santangeli P, Swarup V, Pimentel R, Mansour MC, D'Avila A, Sanchez JE, Burkhardt JD, Chalhoub F, Mohanty P, Coffey J, Shaik N, Monir G, Reddy VY, Ruskin J, Natale A.
    J Am Coll Cardiol; 2012 Mar 27; 59(13):1168-74. PubMed ID: 22305113
    [Abstract] [Full Text] [Related]

  • 8. Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.
    Maddox W, Kay GN, Yamada T, Osorio J, Doppalapudi H, Plumb VJ, Gunter A, McElderry HT.
    J Cardiovasc Electrophysiol; 2013 Aug 27; 24(8):861-5. PubMed ID: 23577951
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation.
    Kaseno K, Naito S, Nakamura K, Sakamoto T, Sasaki T, Tsukada N, Hayano M, Nishiuchi S, Fuke E, Miki Y, Nakamura K, Yamashita E, Kumagai K, Oshima S, Tada H.
    Circ J; 2012 Aug 27; 76(10):2337-42. PubMed ID: 22785434
    [Abstract] [Full Text] [Related]

  • 10. Apixaban for periprocedural anticoagulation during catheter ablation of atrial fibrillation: a systematic review and meta-analysis of 1691 patients.
    Blandino A, Bianchi F, Biondi-Zoccai G, Grossi S, Conte MR, Rametta F, Gaita F.
    J Interv Card Electrophysiol; 2016 Sep 27; 46(3):225-36. PubMed ID: 27217030
    [Abstract] [Full Text] [Related]

  • 11. Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.
    Bassiouny M, Saliba W, Rickard J, Shao M, Sey A, Diab M, Martin DO, Hussein A, Khoury M, Abi-Saleh B, Alam S, Sengupta J, Borek PP, Baranowski B, Niebauer M, Callahan T, Varma N, Chung M, Tchou PJ, Kanj M, Dresing T, Lindsay BD, Wazni O.
    Circ Arrhythm Electrophysiol; 2013 Jun 27; 6(3):460-6. PubMed ID: 23553523
    [Abstract] [Full Text] [Related]

  • 12. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.
    Armbruster HL, Lindsley JP, Moranville MP, Habibi M, Khurram IM, Spragg DD, Berger RD, Calkins H, Marine JE.
    Ann Pharmacother; 2015 Mar 27; 49(3):278-84. PubMed ID: 25515868
    [Abstract] [Full Text] [Related]

  • 13. Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy.
    Loughlin G, Romaniega TD, Garcia-Fernandez J, Calvo D, Salgado R, Alonso A, Li X, Arenal A, González-Torrecilla E, Atienza F, Fernández-Avilés F.
    J Interv Card Electrophysiol; 2016 Mar 27; 45(2):149-58. PubMed ID: 26739484
    [Abstract] [Full Text] [Related]

  • 14. Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation.
    Sardar P, Nairooz R, Chatterjee S, Wetterslev J, Ghosh J, Aronow WS.
    Am J Cardiol; 2014 Apr 01; 113(7):1173-7. PubMed ID: 24513472
    [Abstract] [Full Text] [Related]

  • 15. Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.
    Kim JS, She F, Jongnarangsin K, Chugh A, Latchamsetty R, Ghanbari H, Crawford T, Suwanagool A, Sinno M, Carrigan T, Kennedy R, Saint-Phard W, Yokokawa M, Good E, Bogun F, Pelosi F, Morady F, Oral H.
    Heart Rhythm; 2013 Apr 01; 10(4):483-9. PubMed ID: 23237911
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
    Providência R, Albenque JP, Combes S, Bouzeman A, Casteigt B, Combes N, Narayanan K, Marijon E, Boveda S.
    Heart; 2014 Feb 01; 100(4):324-35. PubMed ID: 23878175
    [Abstract] [Full Text] [Related]

  • 17. Network meta-analysis of efficacy and safety of competitive oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation.
    Li PJ, Xiao J, Yang Q, Feng Y, Wang T, Liu GJ, Liang ZA.
    J Interv Card Electrophysiol; 2016 Sep 01; 46(3):213-24. PubMed ID: 27001171
    [Abstract] [Full Text] [Related]

  • 18. Periprocedural dabigatran in atrial fibrillation ablation: a new kid on the block.
    Pelargonio G, Perna F.
    J Cardiovasc Electrophysiol; 2013 Aug 01; 24(8):866-8. PubMed ID: 23647979
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.